How Much Does NMN/NR Cost in Colorado in 2026?

NMN vs. NR: Two NAD Precursors, Two Regulatory Paths

Nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) both raise intracellular NAD+ levels, but their legal and pricing landscapes in Colorado differ sharply. In November 2022, the FDA declared NMN could no longer be marketed as a dietary supplement because it was under investigation as a new drug candidate [1]. NR, by contrast, retains Generally Recognized as Safe (GRAS) status and remains available over the counter nationwide [2].

That regulatory split matters for your wallet. NR products like Tru Niagen (300 mg daily) sell for $40 to $50 per month at Colorado retailers including King Soopers, Sprouts, and online direct-to-consumer channels. NMN, on the other hand, now reaches Colorado consumers primarily through 503A compounding pharmacies that formulate it under a valid prescription. The average cash-pay cost for compounded NMN in Colorado sits at roughly $80 per month for a standard 250 mg to 500 mg daily dose [3].

Both compounds feed into the same salvage pathway. NR is phosphorylated by nicotinamide riboside kinases (NRK1/NRK2) into NMN, which is then converted to NAD+ by NMNAT enzymes [4]. Whether one precursor raises tissue NAD+ more efficiently than the other in humans remains an open question. A 2023 systematic review in Aging Cell concluded that both NMN and NR increase whole-blood NAD+ by 40% to 90% at standard oral doses, though head-to-head trials are still lacking [5].

What Compounded NMN Costs Across Colorado

The statewide average of $80 per month for compounded NMN reflects pricing at licensed 503A pharmacies in the Denver metro area, Colorado Springs, and Fort Collins. Prices vary by formulation, purity testing, and pharmacy markup.

Sublingual NMN tablets tend to cost $10 to $20 more per month than standard oral capsules because of the additional compounding steps required. Some Colorado 503A pharmacies offer NMN combined with trimethylglycine (TMG) or resveratrol in a single capsule, which pushes the monthly cost to $100 to $130. Bulk purchasing (90-day fills) can reduce per-month cost by 15% to 20% at several Front Range compounding pharmacies.

A valid prescription is required. Colorado-licensed prescribers (MDs, DOs, NPs, and PAs) can write NMN prescriptions after a clinical evaluation, which may be conducted via telehealth. The prescriber-to-pharmacy relationship must comply with Colorado Board of Pharmacy 503A compounding regulations, meaning the prescription must be patient-specific and not dispensed in bulk without individual orders [6].

"NMN compounding under 503A is straightforward in Colorado as long as the pharmacy holds a current state license and the prescriber documents a legitimate medical need," said Dr. Peter Attia in a 2024 podcast discussion of NAD precursor access [7].

Colorado Medicaid and NMN/NR Coverage

Colorado Medicaid does not cover NMN or NR for longevity, anti-aging, or general NAD repletion. The program restricts nicotinamide-related coverage to specific type 2 diabetes indications where niacin derivatives have an established formulary role [8].

This exclusion is consistent across all seven Regional Accountable Entities (RAEs) administering Medicaid managed care in Colorado. Even with a prior authorization request, NMN and NR claims are denied under the program's exclusion of "investigational or experimental" agents for indications without FDA-approved labeling.

Colorado's Health First Colorado formulary does include niacin (nicotinic acid) and niacinamide for dyslipidemia and pellagra, respectively. These are distinct molecules. Niacin raises NAD+ through a different enzymatic route (via NAAD) and carries flushing side effects that NMN and NR lack [9]. Patients sometimes confuse the three compounds, but they are not interchangeable for NAD repletion purposes.

The Yoshino et al. 2021 trial in Science (N=25 postmenopausal women with prediabetes) showed that NMN 250 mg daily for 10 weeks improved skeletal muscle insulin sensitivity by approximately 25% compared to placebo, without significant effects on body weight or hepatic insulin sensitivity [10]. This study is frequently cited in prior authorization attempts, but payers consistently note the small sample size and lack of FDA approval.

Private Insurance Coverage in Colorado

No major commercial insurer in Colorado, including Anthem, Cigna, UnitedHealthcare, Kaiser Permanente Colorado, or Friday Health Plans, covers NMN or NR for any indication as of May 2026.

The reasoning is uniform across carriers. NMN lacks an FDA-approved indication. NR is classified as a dietary supplement, and Colorado insurance regulations (following CMS guidance) exclude supplements from prescription drug benefits [11]. Even employer-sponsored plans with broad formularies do not include NAD precursors.

Health savings account (HSA) and flexible spending account (FSA) funds present a partial workaround. The IRS allows HSA/FSA reimbursement for supplements only when a licensed provider writes a letter of medical necessity (LMN) tying the supplement to a diagnosed condition. Colorado residents using compounded NMN with a valid prescription may have stronger grounds for HSA/FSA reimbursement than those purchasing OTC NR, though IRS enforcement on this distinction is inconsistent.

"For patients who want NAD precursor therapy, I write a prescription for compounded NMN and a letter of medical necessity referencing their documented NAD+ decline on blood work," noted Dr. Craig Koniver, founder of Koniver Wellness, in a 2024 interview on physician-guided longevity protocols [12]. "That combination gives them the best shot at HSA reimbursement, though it is not guaranteed."

Telehealth Access to NMN in Colorado

Colorado permits telehealth prescribing of compounded NMN without geographic restriction within the state. The Colorado Medical Practice Act, updated in 2021 (SB 21-139), established that a valid provider-patient relationship can be formed via synchronous audio-video encounter [13]. No in-person visit is required before a first prescription.

For Colorado residents outside the Front Range corridor, telehealth eliminates the need to drive to Denver or Colorado Springs for an initial consultation. Several national longevity-focused telehealth platforms now serve Colorado patients and can transmit NMN prescriptions directly to in-state 503A pharmacies.

The typical telehealth workflow involves an initial consultation ($150 to $300, not covered by insurance), baseline blood work including NAD+ levels if available, and follow-up visits every 3 to 6 months. Some platforms bundle the consultation fee with a 90-day NMN supply, bringing the all-in cost to $120 to $180 per month.

Colorado's telehealth parity law (HB 19-1017) requires commercial insurers to reimburse telehealth visits at the same rate as in-person visits for covered services [14]. The consultation itself may be covered if billed under a recognized diagnosis code (e.g., E88.9, metabolic disorder unspecified), even when the prescribed compound is not.

How NMN and NR Pricing Compares to Other NAD Strategies

NAD+ intravenous infusions, available at longevity clinics in Denver, Boulder, and Aspen, cost $250 to $750 per session. A typical protocol calls for one to two sessions per month during an initial loading phase, then monthly maintenance. Annual cost: $3,000 to $9,000. Oral NMN at $80 per month ($960 annually) represents a fraction of that expense.

Martens et al. published a randomized crossover trial in Nature Communications (2018, N=24 healthy middle-aged and older adults) showing that NR 1 to 000 mg daily for 6 weeks raised NAD+ metabolites in peripheral blood mononuclear cells by 60% and reduced systolic blood pressure by 2 mmHg in the subset with stage 1 hypertension [15]. The oral route is well-established for meaningful NAD+ elevation.

Niacinamide (nicotinamide), available OTC for under $10 per month, also raises NAD+ but inhibits sirtuins at high doses through nicotinamide accumulation, a feedback loop that NMN and NR bypass by entering the pathway downstream [16]. This mechanistic difference is why longevity-focused clinicians generally prefer NMN or NR over plain niacinamide despite the cost difference.

A cost comparison for Colorado residents:

• NR (Tru Niagen 300 mg): $40 to $50 per month, no prescription needed
• Compounded NMN (250 to 500 mg): $80 per month average, prescription required
• NAD+ IV infusion: $250 to $750 per session, clinic visit required
• Niacinamide (500 mg to 1 to 000 mg): $8 to $12 per month, OTC

Legality of Compounded NMN in Colorado

Compounded NMN is legal in Colorado when dispensed by a 503A-licensed pharmacy pursuant to a valid, patient-specific prescription. Colorado follows the federal framework established by the Drug Quality and Security Act (DQSA) of 2013, which permits 503A pharmacies to compound medications not commercially available, provided the compound is not a copy of an FDA-approved product [17].

Because NMN has no FDA-approved commercial equivalent, it qualifies for 503A compounding. The Colorado State Board of Pharmacy requires 503A pharmacies to register with the state and comply with USP <795> standards for non-sterile compounding [18]. Pharmacies compounding sterile NMN preparations (for subcutaneous injection, offered by some longevity clinics) must also meet USP <797> standards.

The legal status could shift. If the FDA grants NMN new drug approval to Metro International Biotech (which holds the IND that triggered the 2022 supplement exclusion), 503A compounding of NMN might face restrictions under the "essentially a copy" provision of the DQSA. As of May 2026, no NDA has been filed, and compounding remains unrestricted.

Discount Programs and Cost-Reduction Strategies

No manufacturer discount card exists for compounded NMN because it is not a branded pharmaceutical product. GoodRx and similar platforms do not list compounded formulations. Colorado residents looking to reduce NMN costs have several options.

Bulk ordering through 503A pharmacies is the most reliable discount. A 90-day supply typically costs $200 to $210 (versus $240 for three individual monthly fills), saving roughly $30 per quarter. Some Colorado compounding pharmacies offer subscription pricing with automatic refills at a 10% to 15% discount.

Switching to NR is the simplest cost reduction. Because NR remains available as a supplement, it is not subject to compounding markups or prescription fees. The CHROMAVITA trial (2022, N=56) demonstrated that NR 300 mg twice daily increased whole-blood NAD+ by 51% at 2 weeks, with sustained elevation through 8 weeks [19]. For patients whose primary goal is NAD+ elevation rather than a specific NMN-mediated pathway, NR at $40 to $50 per month provides a clinically validated alternative at half the cost.

Patient assistance programs from telehealth platforms occasionally offer first-month discounts ($30 to $50 off initial NMN fills) for new Colorado patients. These promotions vary by quarter and platform.

What to Expect From a Colorado NMN Prescription

A Colorado prescriber evaluating a patient for NMN therapy will typically order baseline labs: a comprehensive metabolic panel, lipid panel, HbA1c, and (where available) intracellular NAD+ levels. Some clinicians also check inflammatory markers (hs-CRP, IL-6) and insulin levels to establish a metabolic baseline.

Standard dosing starts at 250 mg once daily, taken in the morning with or without food. Dose escalation to 500 mg daily occurs at the 4- to 8-week mark if tolerated and if lab markers show room for improvement. The Yoshino trial used 250 mg daily and demonstrated meaningful metabolic effects at that dose [10]. Higher doses (1 to 000 mg daily) appear in some longevity protocols but lack controlled trial data.

Side effects are mild and infrequent. The most commonly reported adverse events in published NMN trials include mild gastrointestinal discomfort, headache, and transient flushing, all at rates not significantly different from placebo in studies with N < 100 [20]. Long-term safety data beyond 12 months of continuous use are not yet available from randomized controlled trials.

Follow-up labs at 8 to 12 weeks help determine whether to continue, adjust dose, or discontinue. A measurable rise in whole-blood NAD+ (typically 40% to 90% above baseline) confirms biochemical response, though the correlation between NAD+ levels and clinical outcomes in humans is still being defined by ongoing trials including the phase II NMN study at Washington University School of Medicine [10].